Related Experiment Video
Updated: Jun 3, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
Large multimodal models: boon or burden for low- and middle-income countries
Rohit Malpani1, Keymanthri Moodley2
1World Health Organization, Research for Health Department, Avenue Appia 20, Geneva 1211, Switzerland.
Abstract:
Large multimodal models, a type of generative artificial intelligence (AI), could contribute to wider government efforts to achieve universal health coverage if ethical challenges are proactively addressed during the design and deployment of these AI technologies. The World Health Organization has published new guidance to highlight the risks and benefits of large multimodal models and recommendations to effectively govern this technology.
More Related Videos
Related Concept Videos
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Analysis of Population Pharmacokinetic Data
Clearance Models: Noncompartmental Models
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

